Furthermore, Yang et al. demonstrated that the quality of CD8+ CD19 CAR-T cells in terms of the production of granzyme and cytokine release was enhanced by BH3 mimetics in their study, and this might be due to the up-regulated target antigen CD19 on tumor cells by BH3 [39]. Here, CD19 is linked to neoplasm.